PHARMA News

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Aug 1 05:38 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jul 1 00:48 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jun 5 00:47 ET

Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)

May 27 01:58 ET

PHARMA: AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : MATERIAL UNCERTAINTY RELATED TO GOING CONCERN

May 8 07:19 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

May 2 05:33 ET

PHARMA: TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS

Apr 23 01:06 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Apr 2 06:07 ET

PHARMA: Change in Risk Committee - DATO' DR FARIDAH ARYANI BINTI MD YUSOF

Mar 27 01:11 ET

PHARMA: Change in Risk Committee - DATO' MOHD ZAHIR BIN ZAHUR HUSSAIN

Mar 27 01:10 ET

PHARMA: Change in Risk Committee - PUAN SARAH AZREEN BINTI ABDUL SAMAT

Mar 27 01:10 ET

PHARMA: Change in Nomination and Remuneration Committee - DATO' DR FARIDAH ARYANI BINTI MD YUSOF

Mar 27 01:07 ET

PHARMA: Change in Nomination and Remuneration Committee - TUAN DRS. IMAM FATHORRAHMAN

Mar 27 01:07 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Mar 4 05:03 ET

Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)

Feb 29 01:02 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN

Feb 23 04:00 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN

Feb 19 05:39 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Feb 1 19:20 ET

PHARMA: OTHERS

Jan 4 00:11 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jan 2 04:28 ET